Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Total Liabilities (2016 - 2025)

Tg Therapeutics has reported Total Liabilities over the past 10 years, most recently at $415.2 million for Q4 2025.

  • Quarterly results put Total Liabilities at $415.2 million for Q4 2025, up 16.86% from a year ago — trailing twelve months through Dec 2025 was $415.2 million (up 16.86% YoY), and the annual figure for FY2025 was $415.2 million, up 16.86%.
  • Total Liabilities for Q4 2025 was $415.2 million at Tg Therapeutics, down from $417.8 million in the prior quarter.
  • Over the last five years, Total Liabilities for TGTX hit a ceiling of $426.2 million in Q2 2025 and a floor of $98.2 million in Q3 2021.
  • Median Total Liabilities over the past 5 years was $169.5 million (2023), compared with a mean of $225.0 million.
  • Biggest five-year swings in Total Liabilities: dropped 5.26% in 2022 and later surged 136.84% in 2024.
  • Tg Therapeutics' Total Liabilities stood at $142.5 million in 2021, then fell by 5.26% to $135.0 million in 2022, then increased by 25.26% to $169.1 million in 2023, then soared by 110.15% to $355.3 million in 2024, then increased by 16.86% to $415.2 million in 2025.
  • The last three reported values for Total Liabilities were $415.2 million (Q4 2025), $417.8 million (Q3 2025), and $426.2 million (Q2 2025) per Business Quant data.